Although studies have shown that upregulation of NAT10 promotes EMT, thereby promoting metastasis in hepatocellular carcinoma (Guo et al., 2024), its role in kidney cancer, especially ccRCC, is still poorly understood. Here, NAT10 is linked to hepatocellular carcinoma.